99 related articles for article (PubMed ID: 30873542)
1. PMEPA1/TMEPAI knockout impairs tumour growth and lung metastasis in MDA-MB-231 cells without changing monolayer culture cell growth.
Abdelaziz M; Watanabe Y; Kato M
J Biochem; 2019 May; 165(5):411-414. PubMed ID: 30873542
[TBL] [Abstract][Full Text] [Related]
2. PMEPA1/TMEPAI isoforms function via its PY and Smad-interaction motifs for tumorigenic activities of breast cancer cells.
Puteri MU; Watanabe Y; Wardhani BWK; Amalia R; Abdelaziz M; Kato M
Genes Cells; 2020 Jun; 25(6):375-390. PubMed ID: 32181976
[TBL] [Abstract][Full Text] [Related]
3. [Transmembrane prostate androgen-induced protein 1 (PMEPA1) promotes the migration and maintains mesenchymal-like phenotype of breast cancer cells].
Zou Y; Zhang Y; Wang T; Wang S; Yang A; Jia L; Wang L
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2016 Feb; 32(2):158-62. PubMed ID: 26927372
[TBL] [Abstract][Full Text] [Related]
4. Transforming growth factor-beta increases breast cancer stem cell population partially through upregulating PMEPA1 expression.
Nie Z; Wang C; Zhou Z; Chen C; Liu R; Wang D
Acta Biochim Biophys Sin (Shanghai); 2016 Feb; 48(2):194-201. PubMed ID: 26758191
[TBL] [Abstract][Full Text] [Related]
5. TMEPAI/PMEPA1 enhances tumorigenic activities in lung cancer cells.
Vo Nguyen TT; Watanabe Y; Shiba A; Noguchi M; Itoh S; Kato M
Cancer Sci; 2014 Mar; 105(3):334-41. PubMed ID: 24438557
[TBL] [Abstract][Full Text] [Related]
6. Down-regulation of CITED2 attenuates breast tumor growth, vessel formation and TGF-β-induced expression of VEGFA.
Jayaraman S; Doucet M; Kominsky SL
Oncotarget; 2017 Jan; 8(4):6169-6178. PubMed ID: 28008154
[TBL] [Abstract][Full Text] [Related]
7. Cooperative induction of transmembrane prostate androgen induced protein TMEPAI/PMEPA1 by transforming growth factor-β and epidermal growth factor signaling.
Azami S; Vo Nguyen TT; Watanabe Y; Kato M
Biochem Biophys Res Commun; 2015 Jan; 456(2):580-5. PubMed ID: 25482449
[TBL] [Abstract][Full Text] [Related]
8. Effects of VEGFR1
Meng D; Meng M; Luo A; Jing X; Wang G; Huang S; Luo M; Shao S; Zhao X; Liu R
J Cancer Res Clin Oncol; 2019 Feb; 145(2):411-427. PubMed ID: 30483898
[TBL] [Abstract][Full Text] [Related]
9. PMEPA1/TMEPAI Is a Unique Tumorigenic Activator of AKT Promoting Proteasomal Degradation of PHLPP1 in Triple-Negative Breast Cancer Cells.
Haque MA; Abdelaziz M; Puteri MU; Vo Nguyen TT; Kudo K; Watanabe Y; Kato M
Cancers (Basel); 2021 Sep; 13(19):. PubMed ID: 34638419
[TBL] [Abstract][Full Text] [Related]
10. PMEPA1 promotes androgen receptor-negative prostate cell proliferation through suppressing the Smad3/4-c-Myc-p21 Cip1 signaling pathway.
Liu R; Zhou Z; Huang J; Chen C
J Pathol; 2011 Apr; 223(5):683-94. PubMed ID: 21341270
[TBL] [Abstract][Full Text] [Related]
11.
Sharad S; Dobi A; Srivastava S; Srinivasan A; Li H
Biomolecules; 2020 Aug; 10(9):. PubMed ID: 32842649
[TBL] [Abstract][Full Text] [Related]
12. Epithelial requirement for in vitro proliferation and xenograft growth and metastasis of MDA-MB-468 human breast cancer cells: oncogenic rather than tumor-suppressive role of E-cadherin.
Hugo HJ; Gunasinghe NPAD; Hollier BG; Tanaka T; Blick T; Toh A; Hill P; Gilles C; Waltham M; Thompson EW
Breast Cancer Res; 2017 Jul; 19(1):86. PubMed ID: 28750639
[TBL] [Abstract][Full Text] [Related]
13. PMEPA1, an androgen-regulated NEDD4-binding protein, exhibits cell growth inhibitory function and decreased expression during prostate cancer progression.
Xu LL; Shi Y; Petrovics G; Sun C; Makarem M; Zhang W; Sesterhenn IA; McLeod DG; Sun L; Moul JW; Srivastava S
Cancer Res; 2003 Aug; 63(15):4299-304. PubMed ID: 12907594
[TBL] [Abstract][Full Text] [Related]
14. TGF-β induced TMEPAI/PMEPA1 inhibits canonical Smad signaling through R-Smad sequestration and promotes non-canonical PI3K/Akt signaling by reducing PTEN in triple negative breast cancer.
Singha PK; Pandeswara S; Geng H; Lan R; Venkatachalam MA; Saikumar P
Genes Cancer; 2014 Sep; 5(9-10):320-36. PubMed ID: 25352949
[TBL] [Abstract][Full Text] [Related]
15. Metastasis of hormone-independent breast cancer to lung and bone is decreased by alpha-difluoromethylornithine treatment.
Richert MM; Phadke PA; Matters G; DiGirolamo DJ; Washington S; Demers LM; Bond JS; Manni A; Welch DR
Breast Cancer Res; 2005; 7(5):R819-27. PubMed ID: 16168128
[TBL] [Abstract][Full Text] [Related]
16. TMEPAI regulates EMT in lung cancer cells by modulating the ROS and IRS-1 signaling pathways.
Hu Y; He K; Wang D; Yuan X; Liu Y; Ji H; Song J
Carcinogenesis; 2013 Aug; 34(8):1764-72. PubMed ID: 23615405
[TBL] [Abstract][Full Text] [Related]
17. TMEPAI inhibits TGF-β signaling by promoting lysosome degradation of TGF-β receptor and contributes to lung cancer development.
Bai X; Jing L; Li Y; Li Y; Luo S; Wang S; Zhou J; Liu Z; Diao A
Cell Signal; 2014 Sep; 26(9):2030-9. PubMed ID: 24933703
[TBL] [Abstract][Full Text] [Related]
18. CRISPR/Cas9-mediated gene knockout of NANOG and NANOGP8 decreases the malignant potential of prostate cancer cells.
Kawamura N; Nimura K; Nagano H; Yamaguchi S; Nonomura N; Kaneda Y
Oncotarget; 2015 Sep; 6(26):22361-74. PubMed ID: 26087476
[TBL] [Abstract][Full Text] [Related]
19. PMEPA1, a transforming growth factor-beta-induced marker of terminal colonocyte differentiation whose expression is maintained in primary and metastatic colon cancer.
Brunschwig EB; Wilson K; Mack D; Dawson D; Lawrence E; Willson JK; Lu S; Nosrati A; Rerko RM; Swinler S; Beard L; Lutterbaugh JD; Willis J; Platzer P; Markowitz S
Cancer Res; 2003 Apr; 63(7):1568-75. PubMed ID: 12670906
[TBL] [Abstract][Full Text] [Related]
20. miR‑19a‑3p targets PMEPA1 and induces prostate cancer cell proliferation, migration and invasion.
Feng S; Zhu X; Fan B; Xie D; Li T; Zhang X
Mol Med Rep; 2016 May; 13(5):4030-8. PubMed ID: 27035427
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
